Ductal Carcinoma in Situ Vs Lobular Carcinoma in Situ

One of the more confusing areas in breastmastectomy with a diagnosis of DCIS, be sure
pathology for patients is the difference betweenthat the pathology report includes the following:
ductal carcinoma in situ and lobular carcinoma inthe size of the DCIS, the grade, the presence or
situ (DCIS vs. LCIS). DCIS arises in the largerabsence of necrosis, and the distance the DCIS is
ducts of the breast and LCIS arises within thefrom the surgical margins. All of these factors
lobules of the breast. However, the ducts andinfluence what type of treatment you should
lobules are connected which means that DCISreceive next. Possible therapies include one or
may travel into the lobules and LCIS may travelmore of the following: additional surgery, radiation
up the ducts. For this reason, pathologists rely ontherapy, or endocrine therapy.
the type of cells and pattern of growth toLobular Carcinoma In Situ (LCIS)
determine the diagnosis of DCIS vs. LCIS. Only aLobular carcinoma in situ (LCIS) refers to a
pathologist can make this distinction. In someneoplastic proliferation of cells that fill up the
cases, both DCIS and LCIS are present in thelobules in your breast and may extend into the
same biopsy.duct system.
DCIS and LCIS both increase a patient's relativeUnlike DCIS, LCIS is generally not graded by most
risk for developing invasive breast cancer andpathologists. An exception is a recently described
that risk applies to both breasts. However, DCISentity called "pleomorphic LCIS." Pleomorphic LCIS
is also thought to be a "precursor" to invasiverefers to an in situ carcinoma with the
carcinoma based upon numerous research studies.characteristic features of LCIS, plus more atypical
This is why your surgeon tries to remove allcells and often necrosis (dead cells). Pleomorphic
areas of DCIS from your breast and why manyLCIS can be difficult to distinguish from DCIS in
patients subsequently receive radiation therapy tomany cases, but a special stain called e-cadherin
that breast.can be used to help your pathologist make the
LCIS, on the other hand, has not traditionally beendistinction.
considered to be a "precursor" to invasiveTreatment of LCIS vs. Pleomorphic LCIS
carcinoma, therefore complete removal of LCISIf you have a diagnosis of LCIS on a core needle
and radiation therapy is not required. There isbiopsy, generally your surgeon will want to
emerging data that may change this way ofperform surgery to excise the area of concern,
thinking, but the current standard of care is toalthough this is somewhat controversial in the
treat LCIS and DCIS differently. One exception tomedical literature. If you have a diagnosis of only
this may be pleomorphic LCIS which will beLCIS on your lumpectomy/partial mastectomy,
discussed later.there is no need to worry about clear margins
Ductal Carcinoma In Situ (DCIS)and radiation therapy is not the standard of
DCIS is a complex diagnosis. If you are diagnosed,treatment. Unlike classic LCIS, there is no
it's important to know what grade of DCIS youruniformly accepted standard treatment for
pathologist has assigned (low, intermediate, orpleomorphic LCIS, although many medical teams
high), and whether or not necrosis (dead cells) arechoose to treat it like DCIS.
present.Once you have a diagnosis of LCIS, because you
If you have a diagnosis of DCIS on a core needleare now at increased risk for developing invasive
biopsy, you need to have a surgical procedure tocarcinoma, your medical team may recommend
try and remove all of the DCIS with adequateendocrine therapy.
margins. If you have had a lumpectomy/partial